|
|
|
|
|
|
|
|
|
|
|
|
|
04.03.26 - 01:12
|
Markets Continue to Seesaw in Wake of Mideast Conflict | The Close 3/3/2026 (Bloomberg)
|
|
|
Bloomberg Television brings you the latest news and analysis leading up to the final minutes and seconds before and after the closing bell on Wall Street. Today's guests are Man Group's Matt Rowe, CIBC Private Wealth's Rebecca Babin, UBS Equity Research Analyst Michael Lasser, On CEO Martin Hoffmann, Russell Investments' Kate El-Hillow, Citi's Scott Chronert, CSIS Senior Fellow Natasha Hall, Council on Foreign Relations Senior Fellow Rebecca Patterson, Brookfield Asset Management's Conor Teskey, Invesco's Andrew Schlossberg, and FIFA World Cup 26 NYNJ Host Committee CEO Alex Lasry. (Source: Bloomberg)...
|
|
|
|
|
04.03.26 - 01:01
|
Broadcom Aktie: HSBC bleibt bullish - Zielsenkung wegen Bewertungsdruck im KI-Sektor (Aktiencheck)
|
|
|
London (www.aktiencheck.de) - Broadcom-Aktienanalyse von HSBC:
Die Analysten von HSBC stufen die Aktie von Broadcom Inc. (ISIN: US11135F1012, WKN: A2JG9Z, Ticker-Symbol: 1YD, NASDAQ-Symbol: AVGO) weiterhin mit "buy" ein und senken das Kursziel von 535 auf 450 USD.
Die Bank erwarte, dass die Ergebnisse für das fiskalische erste Quartal sowie der Ausblick auf das zweite Quartal im Rahmen der Schätzungen liegen würden. [mehr]...
|
|
|
|
|
|
|
|
|
|
|
03.03.26 - 22:42
|
′Treat us fairly′: skilled workers face having their dream of settling in UK snatched away (The Guardian)
|
|
|
As government mulls doubling requirement to 10 years, the uncertainty is putting many who came to Britain to work under strainThey came to the UK to build better lives for their families and to work and contribute to British society. And they came with the promise that, after five years of playing by the rules, they would have the chance to get settled status.Now, many on the skilled worker visa – some of them only months from reaching that milestone – face having it snatched away from them under government plans to retroactively double the baseline period qualifying period for indefinite leave to remain to 10 years; plans they say amount to changing the rules of the game while the ball is in play. Continue reading......
|
|
|
|
|
03.03.26 - 22:06
|
Arcturus Therapeutics Announces Fourth Quarter and Fiscal Year 2025 Financial Results and Pipeline Progress (Business Wire)
|
|
|
ARCT-032 (CF) Phase 2 third cohort (28 days, 15 mg) generally safe and well tolerated
ARCT-032 permitted to proceed into 12-week Phase 2 study; dosing to begin H1 2026
Cash runway extended into Q2 2028
Investor conference call at 4:30 p.m. ET todaySAN DIEGO--(BUSINESS WIRE)--$ARCT #ClinicalTrial--Arcturus Therapeutics Holdings Inc. (the “Company”, “Arcturus”, Nasdaq: ARCT), a messenger RNA medicines company focused on the development of liver and respiratory rare disease therapeutics, today announced its financial results for the fourth quarter and fiscal year 2025, and provided corporate updates.
“Arcturus continues to progress its rare disease therapeutic portfolio. We look forward to aligning with regulators on our clinical development strategy for the ornithine transcarbamylase (OTC) deficiency program, and to initiating our Phase 2, 12‑week cystic fibrosis (CF) study in the first half of 2026,” said Joseph Payne, President & CEO of Arcturus. “We remain firmly committed to advancing ou...
|
|
|
|
|
|
|
|
|
|
|
|